MEDNAX Acquires Louisiana-Based Neonatal Group Practice
The practice consists of two physicians who staff the Level III Regional neonatal intensive care unit (NICU) at CHRISTUS St. Frances Cabrini Hospital. The NICU has annual volume of more than 3,500 patient days.
Dr. Nijjar and St. Frances Cabrini Hospital were responsible for establishing the first NICU in central Louisiana more than 25 years ago. Today, the group serves patients from nine parishes in the area and provides an active ground and air transport program covering a 60-mile radius.
The physicians will practice as part of MEDNAX's Pediatrix Medical Group, a national medical group consisting of the nation's leading neonatal, maternal-fetal medicine and pediatric cardiology physicians.
"Our practice has provided care for thousands of babies in central Louisiana, and at this time, we want to add to our successes by bringing the latest advancements and best practices in neonatal care to the patients in our community," said Amar Nijjar, M.D., who will serve as Pediatrix's medical director for the practice. "As part of a national group practice, we'll have the opportunity to collaborate with physicians around the country to share clinical information and participate in clinical quality initiatives that we believe will help us continue to improve care and lead to better outcomes for our patients."
MEDNAX paid cash for the practice, and the transaction is expected to be immediately accretive to its earnings. No additional terms of the transaction were disclosed.
With this acquisition, MEDNAX has completed 11 physician group practice acquisitions during 2009.
MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 275 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 550 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,450 physicians in 33 states and Puerto Rico. Additional information is available at http://www.mednax.com/
Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions, and are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that couldcause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX's most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled "Risk Factors", as well MEDNAX's current reports on Form 8-K,filed with the Securities and Exchange Commission.
SOURCE: MEDNAX, Inc.
Bob Kneeley, Director, Investor Relations